KAINOS Laboratories, Inc. 4556.T Stock
KAINOS Laboratories, Inc. Price Chart
KAINOS Laboratories, Inc. 4556.T Financial and Trading Overview
KAINOS Laboratories, Inc. stock price | 1213 JPY |
Previous Close | 1071 JPY |
Open | 1070 JPY |
Bid | 1072 JPY x 0 |
Ask | 1086 JPY x 0 |
Day's Range | 1059 - 1088 JPY |
52 Week Range | 1000 - 1187 JPY |
Volume | 4K JPY |
Avg. Volume | 6.27K JPY |
Market Cap | 4.53B JPY |
Beta (5Y Monthly) | 0.71 |
PE Ratio (TTM) | 7.8126125 |
EPS (TTM) | 154.93 JPY |
Forward Dividend & Yield | 50 (4.61%) |
Ex-Dividend Date | March 28, 2024 |
1y Target Est | N/A |
4556.T Valuation Measures
Enterprise Value | 5.59B JPY |
Trailing P/E | 7.8126125 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.0200468 |
Price/Book (mrq) | 1.7985553 |
Enterprise Value/Revenue | 1.261 |
Enterprise Value/EBITDA | 17.965 |
Trading Information
KAINOS Laboratories, Inc. Stock Price History
Beta (5Y Monthly) | 0.71 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 1187 JPY |
52 Week Low | 1000 JPY |
50-Day Moving Average | 1038.9 JPY |
200-Day Moving Average | 1042.97 JPY |
4556.T Share Statistics
Avg. Volume (3 month) | 6.27K JPY |
Avg. Daily Volume (10-Days) | 10.79K JPY |
Shares Outstanding | 4.17M |
Float | 2.03M |
Short Ratio | N/A |
% Held by Insiders | 56.72% |
% Held by Institutions | 1.09% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 7.5 |
Trailing Annual Dividend Yield | 0.70% |
5 Year Average Dividend Yield | 191.00% |
Payout Ratio | 0.18010001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2010 |
Most Recent Quarter (mrq) | December 31, 2010 |
Next Fiscal Year End | March 31, 2011 |
Profitability
Profit Margin | 1.86% |
Operating Margin (ttm) | 5.13% |
Gross Margin | 34.96% |
EBITDA Margin | 7.01% |
Management Effectiveness
Return on Assets (ttm) | 2.16% |
Return on Equity (ttm) | 3.11% |
Income Statement
Revenue (ttm) | 4.44B JPY |
Revenue Per Share (ttm) | 996.26 JPY |
Quarterly Revenue Growth (yoy) | 1.50% |
Gross Profit (ttm) | 1.52B JPY |
EBITDA | 311.32M JPY |
Net Income Avi to Common (ttm) | 82.76M JPY |
Diluted EPS (ttm) | 138.75 |
Quarterly Earnings Growth (yoy) | -46.60% |
Balance Sheet
Total Cash (mrq) | 1.03B JPY |
Total Cash Per Share (mrq) | 231.91 JPY |
Total Debt (mrq) | 1.8B JPY |
Total Debt/Equity (mrq) | 66.97 JPY |
Current Ratio (mrq) | 1.019 |
Book Value Per Share (mrq) | 602.706 |
Cash Flow Statement
Operating Cash Flow (ttm) | 277.3M JPY |
Levered Free Cash Flow (ttm) | 206.94M JPY |
Profile of KAINOS Laboratories, Inc.
Country | Japan |
State | N/A |
City | Tokyo |
Address | 38-18, Hongo 2-chome |
ZIP | N/A |
Phone | 81 3 3816 4123 |
Website | https://www.kainos.co.jp |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 133 |
KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test Kit, a liquid form creatinine measurement reagent kit for various makes of automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit. In addition, it provides FGF-23 ELISA Kit, a two-site enzyme-linked immunosorbent assay kit for the measurement of FGF-23 in serum. Further, the company offers point of care testing solutions comprising Swiftgene Norovirus GI/GII Kainos for detecting noroviruses; Statmark FLUstick II for detecting type A and type B influenza virus antigens; and Statmark Strep A for detecting Group A beta-hemolytic streptococci. The company was formerly known as DOMS-IATRON Co., Ltd. and changed its name to KAINOS Laboratories, Inc. in July 1975. KAINOS Laboratories, Inc. was founded in 1975 and is headquartered in Tokyo, Japan.
Q&A For KAINOS Laboratories, Inc. Stock
What is a current 4556.T stock price?
KAINOS Laboratories, Inc. 4556.T stock price today per share is 1213 JPY.
How to purchase KAINOS Laboratories, Inc. stock?
You can buy 4556.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for KAINOS Laboratories, Inc.?
The stock symbol or ticker of KAINOS Laboratories, Inc. is 4556.T.
Which industry does the KAINOS Laboratories, Inc. company belong to?
The KAINOS Laboratories, Inc. industry is Medical Instruments & Supplies.
How many shares does KAINOS Laboratories, Inc. have in circulation?
The max supply of KAINOS Laboratories, Inc. shares is 4.17M.
What is KAINOS Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
KAINOS Laboratories, Inc. PE Ratio is 7.82934300 now.
What was KAINOS Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
KAINOS Laboratories, Inc. EPS is 154.93 JPY over the trailing 12 months.
Which sector does the KAINOS Laboratories, Inc. company belong to?
The KAINOS Laboratories, Inc. sector is Healthcare.